Skip to content

NBP

NovaBridge Biosciences

NASDAQ · Healthcare · Biotechnology · US

$1.30
+3.17%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
0.22x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.75x
Price / sales
—
Price / cash flow
-4.40x

Enterprise value

Enterprise value
-$35.6M
EV / sales
—
EV / EBITDA
0.64x
EV / EBIT
0.59x
Market cap
$150.8M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026